Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.
about
Somatostatin receptor (SSTR) expression and function in normal and leukaemic T-cells. Evidence for selective effects on adhesion to extracellular matrix components via SSTR2 and/or 3The immunohistochemical localisation of somatostatin receptors 1, 2, 3, and 5 in acoustic neuromasLocalisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumoursA review of the use of somatostatin analogs in oncologyLanreotide-induced modulation of 5-fluorouracil or mitomycin C cytotoxicity in human colon cancer cell lines: a preclinical study.
P2860
Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Phase II study of RC-160 (vapr ...... t of metastatic breast cancer.
@ast
Phase II study of RC-160 (vapr ...... t of metastatic breast cancer.
@en
type
label
Phase II study of RC-160 (vapr ...... t of metastatic breast cancer.
@ast
Phase II study of RC-160 (vapr ...... t of metastatic breast cancer.
@en
prefLabel
Phase II study of RC-160 (vapr ...... t of metastatic breast cancer.
@ast
Phase II study of RC-160 (vapr ...... t of metastatic breast cancer.
@en
P2093
P2860
P356
P1476
Phase II study of RC-160 (vapr ...... t of metastatic breast cancer.
@en
P2093
Braybrooke JP
Koukourakis MI
Mitchell K
O'Byrne KJ
Propper DJ
Woodhull J
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690226
P407
P577
1999-03-01T00:00:00Z